Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from
Larry A Chinitz1, Mikhael F El-Chami2, Venkata Sagi3
1NYU Langone Medical Center, New York, New York.
Heart Rhythm
|September 8, 2022
Summary
Leadless pacemakers using accelerometer-based atrioventricular synchrony (AVS) improve quality of life in patients with AV block. This technology offers stable AVS performance without needing upgrades to dual-chamber systems.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Devices
Background:
- Accelerometer-based, mechanically timed atrioventricular synchrony (AVS) has been shown to be feasible with leadless ventricular pacemakers.
- Leadless pacing technology aims to improve patient outcomes and reduce complications associated with traditional pacing systems.
Purpose of the Study:
- To evaluate the performance of a leadless ventricular pacemaker utilizing accelerometer-based algorithms for AVS pacing.
- To characterize the effectiveness of accelerometer-driven AVS in patients with complete atrioventricular block and normal sinus function.
Main Methods:
- A prospective, single-arm study (AccelAV) enrolled 152 patients implanted with the Micra AV leadless pacemaker.
- The study focused on characterizing resting and ambulatory AVS at 1 month in 54 patients with complete AV block and normal sinus function.
- Quality of life was assessed using the EQ-5D-3L questionnaire, and device performance was monitored for 3 months.
Main Results:
- Among 54 patients with complete AV block and normal sinus function, mean resting AVS was 85.4% and ambulatory AVS was 74.8% at 1 month.
- Programming optimization in 20 patients improved mean ambulatory AVS to 82.6% (a 10.5% increase, P <.001).
- Quality of life significantly improved from pre-implant to 3 months (P = .031), with no device upgrades required.
Conclusions:
- Accelerometer-based mechanical atrial sensing via a leadless pacemaker significantly enhances quality of life in selected AV block patients.
- AVS performance remained stable through 3 months, demonstrating the reliability of this leadless pacing approach.
- No patients required upgrades to dual-chamber pacemakers, highlighting the potential of leadless AVS technology.
Related Concept Videos
Electrophysiology of Normal Cardiac Rhythm
6.7K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
6.7K
Conduction System of the Heart
9.7K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
9.7K


